NEW YORK, NY, Brellium, the AI-powered clinical compliance platform trusted by more than 215,000 providers, announced it has raised $23 million in venture funding.
Brellium announced it has raised $23 million in venture funding and unveiled CortexLM - its proprietary system for analyzing patient notes for gaps in care and compliance that cost providers billions. Led by Left Lane Capital and First Round Capital, with participation from Digital Health Venture Partners, Brellium will use this financing to serve more provider groups across additional specialties and go deeper into the revenue cycle.
Brellium is the AI-powered clinical compliance and revenue integrity platform trusted by more than 215,000 providers across all 50 states. Founded in New York City, Brellium audits 100% of clinical documentation and coding, catching compliance risk before it becomes a clawback and surfacing revenue providers have earned but haven't billed. Backed by First Round Capital, Left Lane Capital, Menlo Ventures, and others, Brellium is built by a team on a mission to improve the standard of care across the U.S. healthcare system.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.